Tandem Diabetes Care has been granted a patent for an apparatus and method for diabetes therapy. The technology involves delivering insulin, monitoring blood glucose levels, and adjusting insulin delivery based on real-time data to prevent low glucose levels. The system includes a user interface for interactive communication. GlobalData’s report on Tandem Diabetes Care gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Tandem Diabetes Care, Wearable drug delivery devices was a key innovation area identified from patents. Tandem Diabetes Care's grant share as of May 2024 was 20%. Grant share is based on the ratio of number of grants to total number of patents.
Automated insulin pump system with glucose monitoring and adjustment
A recently granted patent (Publication Number: US11986292B2) outlines a method for diabetes therapy involving the delivery of insulin to a user via an insulin pump. The method includes receiving sensor glucose data from a continuous glucose monitor, monitoring the data while insulin is being delivered, and comparing it to a target low glucose level. By continuously monitoring the rate of change in blood glucose levels, the system can predict potential risks of hypoglycemia and provide notifications to the user. In response to the risk, the basal rate of insulin delivery can be adjusted to mitigate the potential low glucose levels.
Furthermore, the patent details additional features such as providing notifications with recommendations for corrective actions, such as ingesting carbohydrates, in response to the identified risks. The system also allows for manual instructions from the user to reduce the basal rate of insulin, with the option for the user to accept recommendations for adjustments. Overall, the method aims to enhance diabetes therapy by utilizing real-time sensor data to proactively manage blood glucose levels and prevent hypoglycemic events, ultimately improving the user's overall health and quality of life.
To know more about GlobalData’s detailed insights on Tandem Diabetes Care, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
